Prothena Corp Public (PRTA) Free Cash Flow (2012 - 2026)
Prothena Corp Public's (PRTA) quarterly Free Cash Flow came in at $28.9 million in Q1 2026, up 154.07% year-on-year from $11.4 million in Q1 2025, and up 223.87% quarter-over-quarter from -$23.3 million in Q4 2025.
Prothena Corp Public (PRTA) Free Cash Flow (2012 - 2026) Analysis & Trends
Prothena Corp Public's Free Cash Flow history runs 15 years deep, the most recent figure standing at $28.9 million for Q1 2026.
- On a quarterly basis, Free Cash Flow rose 154.07% year-over-year to $28.9 million in Q1 2026; TTM through Mar 2026 was -$81.4 million, a 37.64% increase from a year earlier, with the FY2025 full-year figure at -$163.7 million, down 8.89% from the prior year.
- Free Cash Flow improved to $28.9 million in Q1 2026 per PRTA's latest filing, from -$23.3 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $28.9 million in Q1 2026 and bottomed at -$73.2 million in Q1 2024.
- The 5-year median for Free Cash Flow is -$40.6 million (2025), against an average of -$31.2 million.
- Across the five-year window, Free Cash Flow plunged 925.69% in 2023 and surged 154.07% in 2026, its largest moves.
- Year by year, Free Cash Flow stood at -$5.1 million in 2022, then plunged by 925.69% to -$52.6 million in 2023, then rose by 9.07% to -$47.8 million in 2024, then soared by 51.25% to -$23.3 million in 2025, then soared by 223.87% to $28.9 million in 2026.
- Per Business Quant, the three latest PRTA Free Cash Flow figures stand at $28.9 million (Q1 2026), -$23.3 million (Q4 2025), and -$40.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 158.09 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.95 Mn |
| 10 | Prothena Corp Public | 458.13 Mn | 128.67 Mn | - | 28.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28.88 Mn |
| Mar 31, 2026 | 28.88 Mn |
| Dec 31, 2025 | -23.31 Mn |
| Dec 31, 2025 | -23.31 Mn |
| Sep 30, 2025 | -40.58 Mn |
| Sep 30, 2025 | -40.58 Mn |
| Jun 30, 2025 | -46.43 Mn |
| Jun 30, 2025 | -46.43 Mn |
| Mar 31, 2025 | -53.41 Mn |
| Mar 31, 2025 | -53.41 Mn |
| Dec 31, 2024 | -47.82 Mn |
| Dec 31, 2024 | -47.82 Mn |
| Sep 30, 2024 | -45.20 Mn |
| Sep 30, 2024 | -45.20 Mn |
| Jun 30, 2024 | 15.82 Mn |
| Jun 30, 2024 | 15.82 Mn |
| Mar 31, 2024 | -73.15 Mn |
| Mar 31, 2024 | -73.15 Mn |
| Dec 31, 2023 | -52.59 Mn |
| Dec 31, 2023 | -52.59 Mn |